| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,499 |
2,904 |
$132K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,663 |
2,047 |
$116K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
67 |
67 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
270 |
230 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
57 |
57 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
485 |
370 |
$6K |
| 99385 |
|
63 |
57 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
112 |
99 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
41 |
41 |
$3K |
| 93000 |
|
658 |
584 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
3,039 |
2,287 |
$2K |
| 99443 |
|
68 |
46 |
$1K |
| 3074F |
|
1,494 |
1,212 |
$550.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
314 |
233 |
$480.53 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
13 |
$471.65 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
14 |
12 |
$246.25 |
| 99442 |
|
14 |
13 |
$239.41 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
184 |
172 |
$203.20 |
| 92552 |
|
285 |
273 |
$202.72 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,157 |
882 |
$164.99 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
64 |
62 |
$19.86 |
| 99000 |
|
3,880 |
2,926 |
$15.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
152 |
127 |
$10.48 |
| 99406 |
|
13 |
12 |
$9.15 |
| 99173 |
|
174 |
170 |
$3.31 |
| 0518F |
|
41 |
32 |
$0.00 |
| 3725F |
|
1,148 |
899 |
$0.00 |
| 3078F |
|
1,252 |
1,001 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
171 |
116 |
$0.00 |
| 1159F |
|
613 |
500 |
$0.00 |
| 3288F |
|
41 |
32 |
$0.00 |
| 1160F |
|
611 |
499 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
67 |
59 |
$0.00 |
| 90461 |
|
12 |
12 |
$0.00 |
| 90734 |
|
16 |
16 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
215 |
147 |
$0.00 |
| G2197 |
Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user |
900 |
761 |
$0.00 |
| 1036F |
|
1,060 |
825 |
$0.00 |
| 1125F |
|
320 |
208 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
263 |
202 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
41 |
32 |
$0.00 |
| 3079F |
|
115 |
93 |
$0.00 |
| 1170F |
|
41 |
32 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
87 |
40 |
$0.00 |
| 1126F |
|
50 |
21 |
$0.00 |